|
|
Home > Healthcare > Medical > Telemedicine, IT & Ehealth
IT Software Tools for Life Science and Drug Discovery R&D
|
|
This report examines the growing worldwide IT software and services market for the life science and drug discovery R&D community. The broad and high-level study takes a business focus and analyzes this interesting vertical market that supports key biomedical advancements.
The emergence of big-budget, life science and drug discovery R&D initiatives sponsored by world governments and other players, combined with the rapid deployments of many types of new analytical instruments has created an incredible set of drug discovery opportunities and challenges for academic labs, R&D institutes and drug making companies alike. Their enormous data output is driving the need to acquire key IT software tools and service solutions even in a major recession.
Big pharma and biotech companies continue to suffer from high R&D costs, drug patent expirations, lower new drug product output, more competition, regulatory challenges and other issues. A growing number of drug makers have turned to reorganizing their business models and are using powerful computer infrastructure and IT software solutions that will help transform their companies with next generation R&D capabilities. They hope to shorten their drug R&D timelines and reduce costs.
The study analyzes the market for IT software tools and services that enable life science and drug R&D. The report segments the software tools and services market by key R&D technology areas that map to drug R&D functions. The R&D tools, such as DNA arrays, next-generation sequencing, cell analysis, biomarkers, knowledge management, ELNs, LIMS and others are discussed.
This report discusses the interesting IT software topics with key findings. The study estimates that the worldwide IT software and services market for life science and drug R&D will reach $1.8 billion in 2009, with a strong growth rate. The research report is for marketers, business development, top executives, investors, VCs, consultants, R&D managers, or entrepreneurs. The report discusses a number of interesting customer case studies and includes 21 company profiles. This report uses 41 figures and tables to illustrate the findings. The study features many convenient tables that help the reader scan the details of key trends, market segmentation, revenue outlook, products, key customers and the like.
|
Similar Products
• Global Digital Economy - E-Government, E-Health and E-Education Trends
Published Nov 2009 by Paul Budde Communication Pty Ltd
• Australia - The National Broadband Network
Published Nov 2009 by Paul Budde Communication Pty Ltd
• Weight Reduction Services
Published Nov 2009 by First Research, Inc.
• BI for Drug Development: Oracle Introduces Clinical Development Analytics
Published Nov 2009 by IDC
• Collaboration Cubed: Industry, Government, and Academia Working Together to Improve Health
Published Oct 2009 by IDC
• Oracle Set to Enter the Drug Pedigree Market
Published Oct 2009 by IDC
• Xerox Acquisition of ACS: Implications for the Healthcare Payer Market
Published Oct 2009 by IDC
• Notable News in the Life Sciences: 3Q09
Published Oct 2009 by IDC
• Dell and Perot Systems: Implications for the Healthcare Market
Published Oct 2009 by IDC
• IMS Health Partners with TCS to Deliver KPO Service
Published Oct 2009 by IDC
|
|
|
|
0 items
